Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.

doi:10.1016/S0140-6736(13)61611-6

Journal ArticleDOI

Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.

Harvey Whiteford, +20 more

- 09 Nov 2013 -

The Lancet

- Vol. 382, Iss: 9904, pp 1575-1586

TLDR

The Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) as discussed by the authors was used to estimate the burden of disease attributable to mental and substance use disorders in terms of disability-adjusted life years (DALYs), years of life lost to premature mortality (YLLs), and years lived with disability (YLDs).

About:

This article is published in The Lancet.The article was published on 2013-11-09. It has received 4753 citations till now. The article focuses on the topics: Years of potential life lost & Poison control.

Citations

PDF

Open Access

More filters

Journal ArticleDOI

Association of Hormonal Contraception With Depression

Charlotte Wessel Skovlund, +3 more

- 01 Nov 2016 -

JAMA Psychiatry

TL;DR: Use of hormonal contraception, especially among adolescents, was associated with subsequent use of antidepressants and a first diagnosis of depression, suggesting depression as a potential adverse effect of hormonal contraceptive use.

...read moreread less

Journal ArticleDOI

Climate Change: Challenges and Opportunities for Global Health

Jonathan A. Patz, +4 more

- 15 Oct 2014 -

JAMA

TL;DR: New US-based temperature projections from downscaled climate modeling and to review recent studies on health risks related to climate change and the cobenefits of efforts to mitigate greenhouse gas emissions are reviewed.

...read moreread less

Journal ArticleDOI

How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence

Pim Cuijpers, +5 more

- 01 Oct 2016 -

World Psychiatry

TL;DR: It is concluded that CBT is probably effective in the treatment of MDD, GAD, PAD and SAD; that the effects are large when the control condition is waiting list, but small to moderate when it is care‐as‐usual or pill placebo; and that, because of the small number of high‐quality trials, these effects are still uncertain and should be considered with caution.

...read moreread less

Journal ArticleDOI

Domain-Specific Physical Activity and Mental Health: A Meta-analysis.

Rhiannon L. White, +5 more

- 01 May 2017 -

American Journal of Preventive Medicine

TL;DR: The domain in which physical activity occurs influences the relationship between physical activity and mental health and should, therefore, be considered when developing interventions, treatment programs, and policy guidelines.

...read moreread less

Journal ArticleDOI

EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH).

Brendon Stubbs, +19 more

- 01 Oct 2018 -

European Psychiatry

TL;DR: A meta-review of PA interventions and their impact on health outcomes for people with SMI, including schizophrenia-spectrum disorders, major depressive disorder (MDD) and bipolar disorder makes multiple recommendations to fill existing research gaps and increase the use of PA in routine clinical care aimed at improving psychiatric and medical outcomes.

...read moreread less

Collapse

References

PDF

Open Access

More filters

Journal ArticleDOI

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

David Moher, +4 more

- 21 Jul 2009 -

PLOS Medicine

TL;DR: Moher et al. as mentioned in this paper introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses, which is used in this paper.

...read moreread less

Journal Article

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.

David Moher, +4 more

- 21 Jul 2009 -

Open Medicine

TL;DR: The QUOROM Statement (QUality Of Reporting Of Meta-analyses) as mentioned in this paper was developed to address the suboptimal reporting of systematic reviews and meta-analysis of randomized controlled trials.

...read moreread less

Journal ArticleDOI

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

David Moher, +4 more

- 01 Jan 2010 -

International Journal of Surgery

TL;DR: A structured summary is provided including, as applicable, background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions and implications of key findings.

...read moreread less

Journal ArticleDOI

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Rafael Lozano, +195 more

- 15 Dec 2012 -

The Lancet

TL;DR: The Global Burden of Diseases, Injuries, and Risk Factors Study 2010 aimed to estimate annual deaths for the world and 21 regions between 1980 and 2010 for 235 causes, with uncertainty intervals (UIs), separately by age and sex, using the Cause of Death Ensemble model.

...read moreread less